Pharma Marketing News Vol. 5, #5
Vol. 5, No. 5: May 2006 - EXECUTIVE SUMMARY Welcome to the latest issue of Pharma Marketing News. This is the Executive Summary version....
The Changing World of MSLs: Determining Value
This article is an edited transcript of the May 2006, Pharma Marketing Roundtable discussion, which was devoted to exploring issues surrounding the new roles of medical science liaisons (MSLs) and key opinion leader physicians (KOLs) in physician education and product marketing.
Biotech DTC: Business Not As Usual
There's blood in the water and ad agencies are circlingbiotech companies, trying to entice them into transforming themselves into marketing machines. Some agency people suggest that biotech needs to engage in traditional direct-to-consumer (DTC) advertising. Biotech, however, needs more than DTC as usual.
Peter Rost: Whistle Blower, Pharma Blogger, ???
This article is based on an interview with Rost, Pharma's Black Knight.
Peter Rost: Whistleblower, Pharma Blogger, ???
This article is based on an interview with Rost, Pharma's Black Knight.
Doing a Good Job but Still Not Trusted!
One poll says the pharma industry is doing a good job, another says it can't be trusted. What's up with that?
The Changing World of MSLs: Determining Value
This article is an edited transcript of the May 2006, Pharma Marketing Roundtable discussion, which was devoted to exploring issues surrounding the new roles of medical science liaisons (MSLs) and key opinion leader physicians (KOLs) in physician education and product marketing.
Communicating Risk: Let the Dialogue Begin
This article presents a lightly edited transcript of a Pharma Marketing Roundtable discussion of the March 31, 2006 Coalition for Healthcare Communication's Citizens Petition to the FDA seeking new prescription drug advertising rules to simply the communication of risk information in DTC ads.
Merit of CHC Petition to FDA
Pharma Marketing Network hosted an online survey asking respondents' opinions regarding the the Coalition for Healthcare Communication's petition to the FDA.
Managing Reprints for Better Clinical Support of Marketing
Reprints from medical journals are an integral part of the pharmaceutical industry's physician sales and marketing effort. This article describes the reprint management services provide by Reprints Desk, a new company formed by content professionals with over 50 years of experience serving customers and publishers in healthcare.
